These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 18431484)
21. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies. Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088 [TBL] [Abstract][Full Text] [Related]
22. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat. Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643 [TBL] [Abstract][Full Text] [Related]
23. TLR8 activates HIV from latently infected cells of myeloid-monocytic origin directly via the MAPK pathway and from latently infected CD4+ T cells indirectly via TNF-α. Schlaepfer E; Speck RF J Immunol; 2011 Apr; 186(7):4314-24. PubMed ID: 21357269 [TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. Wille-Reece U; Flynn BJ; Loré K; Koup RA; Miles AP; Saul A; Kedl RM; Mattapallil JJ; Weiss WR; Roederer M; Seder RA J Exp Med; 2006 May; 203(5):1249-58. PubMed ID: 16636134 [TBL] [Abstract][Full Text] [Related]
31. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Gorski KS; Waller EL; Bjornton-Severson J; Hanten JA; Riter CL; Kieper WC; Gorden KB; Miller JS; Vasilakos JP; Tomai MA; Alkan SS Int Immunol; 2006 Jul; 18(7):1115-26. PubMed ID: 16728430 [TBL] [Abstract][Full Text] [Related]
32. TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA. Berger M; Ablasser A; Kim S; Bekeredjian-Ding I; Giese T; Endres S; Hornung V; Hartmann G J Immunother; 2009 Apr; 32(3):262-71. PubMed ID: 19242374 [TBL] [Abstract][Full Text] [Related]
33. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells. Lombardi V; Van Overtvelt L; Horiot S; Moingeon P J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114 [TBL] [Abstract][Full Text] [Related]
34. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses. Wille-Reece U; Wu CY; Flynn BJ; Kedl RM; Seder RA J Immunol; 2005 Jun; 174(12):7676-83. PubMed ID: 15944268 [TBL] [Abstract][Full Text] [Related]
35. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines. Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492 [TBL] [Abstract][Full Text] [Related]
36. TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes. Hofmann H; Vanwalscappel B; Bloch N; Landau NR Retrovirology; 2016 Dec; 13(1):83. PubMed ID: 27905985 [TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor-2/7-mediated T cell activation: An innate potential to augment CD8 Freen-van Heeren JJ Scand J Immunol; 2021 May; 93(5):e13019. PubMed ID: 33377182 [TBL] [Abstract][Full Text] [Related]
38. Differences in TLR7/8 activation between monocytes and macrophages. Eng HL; Hsu YY; Lin TM Biochem Biophys Res Commun; 2018 Feb; 497(1):319-325. PubMed ID: 29448098 [TBL] [Abstract][Full Text] [Related]
39. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. Domingues R; de Carvalho GC; Aoki V; da Silva Duarte AJ; Sato MN J Transl Med; 2016 Jun; 14(1):171. PubMed ID: 27286889 [TBL] [Abstract][Full Text] [Related]